Lower expression of the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT) has been proposed to correlate with TMZ effectiveness and checking for the MGMT tumour status by immunohistochemistry prior starting treatment is recommended [109]. Here, XRCC6P5 is linked to neoplasm.